Evidence map›Paper›PMID 40665614›Full record

ArticleMedical physics2025

Assessing repeatability and confounding factors of magnetic resonance fingerprinting (MRF) for quantitative liver imaging.

Lan Lu, Kevin Stephans, Zhilang Qiu, Sree Tirumani, Yong Chen

Abstract read
In one paragraph

Article in Medical physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lan LuDepartment of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio, USA.
Kevin StephansDepartment of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio, USA.
Zhilang QiuDepartment of Radiology, Case Western Reserve University, Cleveland, Ohio, USA.
Sree TirumaniDepartment of Radiology, Case Western Reserve University, Cleveland, Ohio, USA.
Yong ChenDepartment of Radiology, Case Western Reserve University, Cleveland, Ohio, USA.

Funding

Development of fast diffusion magnetic resonance fingerprinting of the prostate to avoid unnecessary biopsiesR01CA292091 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI Yong Chen, Leonardo Kayat Bittencourt · 2024 to 2026
$3.2M
Development of Magnetic Resonance Fingerprinting (MRF) to Assess Response to Neoadjuvant Chemotherapy in Breast CancerR01CA282516 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI Yong Chen, Dan Ma · 2023 to 2026
$2.4M
Development of Magnetic Resonance Fingerprinting in Kidney for Evaluation of Renal Cell CarcinomaR01CA266702 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI CHEN, YONG, TIRUMANI, SREE HARSHA · 2022 to 2025
$2.0M
Optimized High-Resolution Fast Magnetic Resonance Fingerprinting with Cloud-Based ReconstructionR01NS134849 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Yong Chen, Pew-Thian Yap · 2024 to 2026
$1.9M
NCI NIH HHS R01 CA266702NCI NIH HHS R01 CA282516NCI NIH HHS R01 CA292091NINDS NIH HHS R01 NS134849
6 · The paper itself

Abstract

backgroundAdvanced radiation therapy techniques are increasingly used to treat liver cancers. However, the lack of robust imaging approaches for reliable assessment of early-phase treatment response limits full potential of these therapeutic methods. PURPOSE: To evaluate the performance of a new quantitative MR imaging technique, named magnetic resonance fingerprinting (MRF), in terms of repeatability, reproducibility, and motion sensitivity for quantitative T1 and T2 assessment in hepatic tissues.

methodsA rapid 2D liver MRF technique based on a steady-state free precession sequence was adapted and performed on 3T MR scanners. Quantitative T1 and T2 relaxation time maps with a spatial resolution of 1.6 mm and slice thickness of 5 mm were acquired simultaneously in one breath-hold of 15 s per imaging slice. The accuracy of the liver MRF method was first validated using the standardized water phantom. The repeatability and reproducibility of the liver MRF were further evaluated on five healthy volunteers. Each volunteer was scanned once per week for three consecutive weeks. The effects of dietary status and respiratory motion were further evaluated on three subjects. Finally, a pilot study was performed on one patient with multiple metastatic lesions.

resultsPhantom experiments show the liver MRF method achieved an accurate assessment for T1 up to 2000 ms and T2 up to 300 ms. High-quality quantitative T1 and T2 maps were successfully obtained from all five subjects. Bland-Altman plots show that both T1 and T2 obtained from MRF are highly repeatable, with a coefficient of repeatability of 86 ms for T1 and 9 ms for T2. The quantitative measurements are also highly reproducible with a coefficient of variation of 1.5% ± 0.2% for T1 (range, 1.3%-1.7%) and 4.1% ± 1.3% for T2 (range, 2.9%-5.5%). The MRF-derived T1 and T2 measurements are independent of dietary status. However, clear motion artifacts and vessel blurring were noted in motion-contaminated scan scenarios, which had instructions for 10 s initial breath-holding followed by 5 s shallow breathing. Finally, higher T1 and T2 values were observed in the metastatic lesions as compared to the values obtained in normal liver parenchyma.

conclusionThis pilot study demonstrates that 2D liver MRF can provide high-quality, repeatable, and reproducible T1 and T2 mapping for hepatic tissues. These findings suggest potential applications in tissue/lesion characterization and longitudinal treatment response monitoring in the liver.

Indexed as

LiverMagnetic Resonance ImagingAdultHumansImage Processing, Computer-AssistedLiver NeoplasmsMalePhantoms, ImagingPilot ProjectsReproducibility of ResultsRespirationdietary statusmagnetic resonance fingerprinting (MRF)motion artifactsradiation therapyrepeatabilityreproducibility

Identifiers

PMID40665614
PMCPMC13131443

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.